Enzo Biochem, Inc. (ENZ)

Enzo Biochem Balance Sheet

Financials in millions USD. Fiscal year is August - July.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	82.37	21.6	13.52	47.87	60.15
Short-Term Investments	0	0	29.98	0	0
Cash & Cash Equivalents	82.37	21.6	43.5	47.87	60.15
Cash Growth	281.30%	-50.34%	-9.12%	-20.42%	0.17%
Receivables	4.81	4.76	10.2	9.14	10.74
Inventory	7.94	9.52	12.65	7.78	7.84
Other Current Assets	3.34	6.94	4.23	3.98	2.73
Total Current Assets	98.46	42.82	70.58	68.77	81.45
Property, Plant & Equipment	16.71	16.02	33.61	34.4	14.25
Goodwill and Intangibles	0	0	7.7	7.99	8.48
Other Long-Term Assets	6.71	16.77	1.81	1.39	2.45
Total Long-Term Assets	23.42	32.79	43.11	43.77	25.19
Total Assets	121.88	75.61	113.69	112.54	106.64
Accounts Payable	3.58	3.72	8.12	8.5	7.26
Current Debt	3.57	0.9	3.65	11.47	0.39
Other Current Liabilities	32.85	8.41	14.3	12.83	8.36
Total Current Liabilities	39.99	13.02	26.08	32.8	16.01
Long-Term Debt	3.43	8.13	19.03	21.36	4.6
Total Long-Term Liabilities	3.43	8.13	19.03	21.36	4.6
Total Liabilities	43.42	21.15	45.11	54.16	20.61
Total Debt	7	9.03	22.68	32.82	4.99
Debt Growth	-22.47%	-60.20%	-30.89%	557.21%	-
Retained Earnings	-268.35	-288.64	-270.38	-278.25	-249.73
Comprehensive Income	1.88	3.15	1.35	1.68	2.58
Shareholders' Equity	78.46	54.46	68.59	58.38	86.03
Net Cash / Debt	75.38	12.58	20.82	15.04	55.15
Net Cash / Debt Growth	499.31%	-39.59%	38.40%	-72.72%	-8.14%
Net Cash Per Share	1.53	0.26	0.43	0.32	1.16
Working Capital	58.47	29.8	44.51	35.96	65.44
Book Value Per Share	1.60	1.12	1.42	1.22	1.82

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).